Pancreatic cancer is one of the most aggressive forms of cancer, often diagnosed at a late stage and associated with a poor prognosis. However, some patients manage to defy the odds with personalized care and a comprehensive approach.
One such case is that of TD, a 78-year-old male diagnosed with stage 3 pancreatic cancer in 2019. Under the guidance of Dr. Meakin, an integrative oncologist specializing in repurposed medications for cancer, TD has achieved No Evidence of Disease (NED) and maintained his health through a multifaceted treatment plan.
Initial Diagnosis and Symptoms
TD was diagnosed in October 2019 with stage 3 pancreatic cancer, which had metastasized to the small and large intestines and lymph nodes.
His initial symptoms included loss of appetite, weight loss, fatigue, and general malaise—common signs of pancreatic cancer.
A Comprehensive Treatment Plan with Dr. Meakin
TD’s remarkable outcome was the result of a carefully crafted treatment plan that combined both conventional medical interventions and alternative therapies:
1. Surgical Interventions
TD underwent two surgeries in late 2019 to remove cancerous tissue, setting the foundation for further treatments.
2. Chemotherapy and Alternative Therapies
In January 2020, TD began a Gemcitabine-based chemotherapy regimen, complemented by high-dose Vitamin C injections and pulsing metabolic strategies under Dr. Meakin’s guidance. These alternative therapies helped to enhance the chemotherapy’s effects while reducing its side effects. TD reported that this combination of alternative therapies, dietary changes, and juicing significantly improved his tolerance to chemotherapy.
3. Radiation Therapy
Following chemotherapy, TD underwent a month of radiation therapy, which played a crucial role in eradicating any remaining cancer cells.
4. Repurposed Medications
A key component of TD’s treatment plan, implemented by Dr. Meakin, involved repurposed metabolically acting medications such as Metformin, Doxycycline, Atorvastatin, and Mebendazole. These medications, typically used for other conditions, were employed to target cancer cells. TD reported no side effects from these medications, which he has been taking since March 2020.
5. Supplements
In addition to medical treatments, TD incorporated supplements like Vitamin D3, Vitamin K2, Omega-3 Fish Oils, and Melatonin, further supporting his health and recovery.
Recurrence and Remission
In May 2020, TD experienced a brief recurrence, but with continued treatment under Dr. Meakin, he has been in No Evidence of Disease (NED) status since then. This is an exceptional outcome, particularly for a patient with advanced pancreatic cancer.
Lifestyle Changes
TD’s remarkable recovery is not only attributed to medical interventions but also to his commitment to maintaining a healthy lifestyle:
> Diet: TD follows a diet rich in salmon, salads, and clean meats, while limiting sugar intake, a cornerstone of the metabolic approach promoted by Dr. Meakin.
> Exercise: TD remains active, engaging in resistance training, cardio, biking, and walking three times a week. These activities have helped him maintain a BMI of 25.1 and a weight of 175 lbs.
> Sleep: TD ensures he gets over seven hours of sleep each night, which is essential for maintaining energy and overall well-being.
TD also attributes his success to the unwavering support of his wife, who took an active role in researching alternative therapies and repurposed medications. Together with Dr. Meakin’s expertise, they developed a personalized plan that addressed both the cancer and its side effects. TD strongly believes that diet and metabolic health play a critical role in cancer survivorship.
***
“Persistence, personalized care, and a flexible approach can turn the tide, even with a daunting diagnosis like pancreatic cancer.
In TD’s case, we adapted our strategies at every step, blending conventional and repurposed therapies, which allowed him to live not just longer, but with vitality. It’s a testament to the power of integrative oncology, where persistence doesn’t just pay off—it transforms lives,” says Dr. Charles J. Meakin, TD’s treating integrative oncologist.
***
Pancreatic Cancer Survival Rates: Defying the Odds
Pancreatic cancer is known for its low survival rates, especially when diagnosed at an advanced stage:
- 1-Year Survival Rate: Around 38%
- 3-Year Survival Rate: Approximately 10-15%
- 5-Year Survival Rate: Around 7.2%
Despite these grim statistics, TD’s story is a testament to the potential of multifaceted treatment approaches.
Conclusion: The Power of Integrative Oncology
TD’s case is a remarkable example of how personalized, integrative care can lead to exceptional outcomes, even in advanced cases like stage 3 pancreatic cancer. Under the care of Dr. Meakin, who specializes in repurposed medications and alternative cancer therapies, TD was able to achieve remission and maintain a healthy, active lifestyle.
His journey highlights the importance of exploring innovative treatment options, maintaining a healthy lifestyle, and having a strong support system.
For patients and families facing a difficult cancer diagnosis, TD’s case offers a powerful message of hope and the potential for recovery through personalized, integrative oncology.
For more information about Dr. Meakin’s program, click here>>
References
- Current Advances in Pancreatic Cancer Management
- Pancreatic Cancer Prognosis – Johns Hopkins Medicine
- Pancreatic Cancer Survival – Cancer Research UK
- Pancreatic Cancer Survival Rates – Medical News Today
- A Rare Story of Hope: Pancreatic Cancer Treatment at CUIMC
- Pancreatic Cancer Survival Rates – American Cancer Society
- Stage III Pancreatic Cancer Overview – CancerConnect
